Citigroup
CELU icon

Citigroup’s Celularity CELU Stock Holding History

Citigroup’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,951
Closed -$5.5K – 5988
2025
Q4 		$5.5K Buy
+4,951
New +$8.88K ﹤0.01% 5218
2024
Q1 		– Sell
-1
Closed -$3 – 5661
2023
Q4 		$3 Sell
1
-13
-93% -$28 ﹤0.01% 5656
2023
Q3 		$32 Hold
14
– – ﹤0.01% 5560
2023
Q2 		$76 Buy
+14
New +$90 ﹤0.01% 5464
2023
Q1 		– Sell
-203
Closed -$2.62K – 5534
2022
Q4 		$2.62K Buy
203
+32
+19% +$590 ﹤0.01% 5166
2022
Q3 		$4K Buy
171
+9
+6% +$273 ﹤0.01% 5285
2022
Q2 		$5K Sell
162
-251
-61% -$20.4K ﹤0.01% 5600
2022
Q1 		$36K Buy
+413
New +$24.7K ﹤0.01% 4873
2021
Q4 		– Sell
-145
Closed -$10K – 5845
2021
Q3 		$10K Buy
+145
New +$11.7K ﹤0.01% 5459
2020
Q4 		– Sell
-5,000
Closed -$525K – 7380
2020
Q3 		$525K Hold
5,000
– – ﹤0.01% 3803
2020
Q2 		$510K Hold
5,000
– – ﹤0.01% 4244
2020
Q1 		$490K Buy
+5,000
New +$495K ﹤0.01% 3891

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Citigroup's CELU Position: Q1 2026 in Review

Citigroup sold out of Celularity (CELU) in Q1 2026, closing a stake of 4,951 shares — an estimated $5.5K sold.

Citigroup first reported a position in CELU in Q1 2020 and held it in 12 quarters. The position peaked at $525K in Q3 2020. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Citigroup reported no remaining Celularity position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 4,951 Celularity shares in Q1 2026, an estimated $5.5K.
  • Citigroup first reported a position in Celularity in Q1 2020 and held it in 12 quarters.
  • Citigroup's Celularity position peaked at $525K in Q3 2020.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.